
Home Consortium Limited
ASX:HMC.AX
4.08 (AUD) • At close July 2, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
2025 Q2 | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 135.5 | 56.082 | 40.223 | 40.865 | 28.665 | 50.213 | 28.479 | 32.102 | 37.7 | 39.6 | 33.7 | 28.5 | 20.7 |
Cost of Revenue
| 0 | 15.741 | 4.275 | 13.788 | 11.179 | 6.778 | 7.576 | 10.394 | 13.6 | 16.3 | 14.6 | 0 | 13.5 |
Gross Profit
| 135.5 | 40.341 | 35.948 | 27.077 | 17.486 | 43.435 | 20.903 | 21.708 | 24.1 | 23.3 | 19.1 | 28.5 | 7.2 |
Gross Profit Ratio
| 1 | 0.719 | 0.894 | 0.663 | 0.61 | 0.865 | 0.734 | 0.676 | 0.639 | 0.588 | 0.567 | 1 | 0.348 |
Reseach & Development Expenses
| 0 | 0 | 1.758 | 1.755 | 1.339 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 22.4 | 11.602 | 13.998 | 10.524 | 8.376 | 12.553 | 9.019 | 6.474 | 4.509 | 4.208 | 3.9 | 5.2 | 2.7 |
Selling & Marketing Expenses
| 42 | 18.109 | 17.591 | -14.367 | 14.498 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 64.4 | 29.711 | 0.566 | 1.049 | 1.066 | 12.553 | 9.019 | 6.474 | 4.509 | 4.208 | 3.9 | 5.2 | 2.7 |
Other Expenses
| 0 | 0 | 0 | 0 | 0 | -12.509 | -9.363 | -6.45 | -4.5 | -4.1 | -4.2 | 0 | -2.7 |
Operating Expenses
| 64.4 | 29.711 | 1.896 | 19.413 | 20.313 | 46.778 | 6.892 | 26.281 | 48.041 | 6.171 | 4.2 | 22.8 | 2.7 |
Operating Income
| 71.1 | 26.371 | 17.802 | 37.352 | 19.749 | 30.926 | 11.54 | 15.258 | 19.6 | 19.2 | 14.9 | 6.3 | 4.5 |
Operating Income Ratio
| 0.525 | 0.47 | 0.443 | 0.914 | 0.689 | 0.616 | 0.405 | 0.475 | 0.52 | 0.485 | 0.442 | 0.221 | 0.217 |
Total Other Income Expenses Net
| 212.3 | 47.309 | -6.129 | 22.678 | 2.041 | -30.533 | 70.952 | -14.698 | -35.5 | -7.3 | -24.7 | -42.7 | -15 |
Income Before Tax
| 283.4 | 73.68 | 0 | 0 | 0 | 0.393 | 49.795 | 0.56 | -15.9 | 11.9 | -15.2 | -19.4 | -10.5 |
Income Before Tax Ratio
| 2.092 | 1.314 | 0 | 0 | 0 | 0.008 | 1.748 | 0.017 | -0.422 | 0.301 | -0.451 | -0.681 | -0.507 |
Income Tax Expense
| 17.1 | 9.413 | 0 | 0 | 0 | 9.853 | 4.221 | 67.487 | 21.9 | 2.3 | -2.8 | 1.1 | -6.2 |
Net Income
| 166.9 | 48.198 | 348.019 | 347.541 | 300.188 | 28.991 | 48.258 | -55.398 | 0.9 | 9.6 | -12.4 | -18.3 | -4.3 |
Net Income Ratio
| 1.232 | 0.859 | 8.652 | 8.505 | 10.472 | 0.577 | 1.695 | -1.726 | 0.024 | 0.242 | -0.368 | -0.642 | -0.208 |
EPS
| 0.43 | 0.14 | 350,330,356 | 347,540,596 | 300,584,039 | 0.097 | 0.17 | -0.19 | 0.004 | 0.049 | -0.091 | -0.2 | -0.022 |
EPS Diluted
| 0.43 | 0.14 | 38,261,000 | 48,369,000 | 2,755,000 | 0.096 | 0.17 | -0.19 | 0.004 | 0.049 | -0.091 | -0.2 | -0.046 |
EBITDA
| 39.4 | 17.275 | 4.887 | 5.986 | -3.359 | 31.446 | 11.54 | 15.258 | 19.6 | 19.2 | 14.9 | 40.3 | 4.5 |
EBITDA Ratio
| 0.291 | 0.308 | 0.121 | 0.146 | -0.117 | 0.626 | 0.405 | 0.475 | 0.52 | 0.485 | 0.442 | 1.414 | 0.217 |